SCHEMBL585575

SCHEMBL585575

CCCCC(OC(N)=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.49
HTR2A P28223 1/20 0.49
HTR2B P41595 1/20 0.49
SIGMAR1 Q99720 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1838455 0.95 ADRB1 (0.48) ADRB1HTR2AHTR2BSIGMAR1
SCHEMBL1837158 0.94 ALDH1A1 (0.48) ADRB1HTR2AHTR2BSIGMAR1
SCHEMBL1840538 0.94 ALDH1A1 (0.48) ADRB1HTR2AHTR2BSIGMAR1
SCHEMBL1838922 0.94 ALDH1A1 (0.48) ADRB1HTR2AHTR2BSIGMAR1
Ammonia Solution, Strong SCHEMBL27725772 0.92 ALDH1A1 (0.47) ADRB1HTR2AHTR2BSIGMAR1
SCHEMBL1835163 0.90 ADRB1 (0.51) ADRB1HTR2AHTR2BSIGMAR1
SCHEMBL1836929 0.87 POLB (0.49)
SCHEMBL1836927 0.87 POLB (0.49)
SCHEMBL6666615 0.85 PABPC1 (0.50)
SCHEMBL17844777 0.85 HTR2A (0.52) HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025077996-A1 SYNTHETIC PROCESS FOR THE MANUFACTURE OF ECTEINASCIDIN COMPOUNDS PHARMA MAR, S.A. (ES) 2025-04-17 WO disclosed
EP-3795561-B1 METHOD FOR PRODUCING CARBAMATE AND METHOD FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2024-11-06 EP disclosed
CN-112020493-B Method for producing urethane and method for producing isocyanate 旭化成株式会社 2023-04-21 CN disclosed
EP-4138923-A1 DRUG ANTIBODY CONJUGATES Pharma Mar, S.A. (ES) 2023-03-01 EP disclosed
EP-3838892-B1 METHOD FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2022-10-12 EP disclosed
US-11352319-B2 Method for producing carbamate and method for producing isocyanate ASAHI KASEI KABUSHIKI KAISHA (JP) 2022-06-07 US disclosed
CN-109803992-B Isocyanate composition and method for producing isocyanate polymer 旭化成株式会社 2022-05-24 CN disclosed
CN-109843963-B Isocyanate composition, method for producing isocyanate polymer, and isocyanate polymer 旭化成株式会社 2022-05-13 CN disclosed
CN-107963982-B Polyisocyanate composition and isocyanate polymer composition 旭化成株式会社 2021-11-12 CN disclosed
EP-3293173-B1 METHOD FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2021-07-28 EP disclosed
US-20110133121-A1 N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-06-09 US disclosed
EP-2322504-A1 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED CARBAMIC ACID ESTER AND PROCESS FOR THE PREPARATION OF ISOCYANATE USING THE N-SUBSTITUTED CARBAMIC ACID ESTER Asahi Kasei Chemicals Corporation (JP) 2011-05-18 EP disclosed
WO-2010115709-A1 A TEXTILE PRODUCT (E.G. AN INSECTICIDE NET) INTELLIGENT INSECT CONTROL (FR) 2010-10-14 WO disclosed
WO-2010046348-A1 TEXTILE PRODUCT FOR KILLING INSECTS INTELLIGENT INSECT CONTROL (FR) 2010-04-29 WO disclosed
CN-1173925-C Process for preparation of carbonates and polycarbonates 索罗蒂亚公司 2004-11-03 CN disclosed
CN-1059435-C Process for preparing carbamate and its polymer MONSANTO CO (US) 2000-12-13 CN disclosed
CN-1047936-C Method for producing pharmaceutical composite containing alkylmelatonins LILLY CO ELI (US) 2000-01-05 CN disclosed
WO-1994008952-A1 PREPARATION OF URETHANE AND CARBONATE PRODUCTS MONSANTO COMPANY (US) 1994-04-28 WO disclosed
US-5302717-A Preparation of urethane and carbonate products MONSANTO COMPANY (US) 1994-04-12 US disclosed
CN-1064807-A Preparation contains the method for the pharmaceutical composition of Alkylmelatonins LILLY CO ELI (US) 1992-09-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352319-B2 Method for producing carbamate and method for producing isocyanate CPS1, CA7, CA4 ADRB1 4796/4885HTR2A 3864/4885HTR2B 3350/4885
US-20110133121-A1 N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound CPS1, ALKBH3, RCC1 ADRB1 4315/4885HTR2A 2971/4885HTR2B 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.